Enter your login e-mail to the account
Search
- Childhood acute leukemia
doc. MUDr. Emília Kaiserová, CSc., MUDr. Alexandra Kolenová, PhD.
(4/2012, Review articles )
- CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(1/2008, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - Simultaneous bi-lineage hematological malignancy in pediatric patient – case report
MUDr. Kristína Horváthová, MUDr. Helena Fillová, MUDr. Ivana Fedoráková, MUDr. Michal Šprlák, MUDr. Júlia Horáková, PhD.
(5/2024, Main topic ) - Cytogenetic and molecular cytogenetic methods in hemato-oncology
Mgr. Petra Nováková, MUDr. Denisa Ilenčíková, PhD.
(2/2010, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Acute myeloblastic leukemia in Slovakia and the presence of the FLT3 mutation
MUDr. Eva Mikušková, PhD.
(2/2021, Original articles ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Myelodysplastic syndrome – classification, pathophysiology
prof. MUDr. Elena Tóthová, CSc.
(1/2014, Spectrum ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Správa z 15. kongresu Európskej hematologickej spoločnosti v Barcelone
MUDr. Ľudmila Demitrovičová
(5/2010, Events ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD.
(2/2023, Review articles ) - Childhood acute lymphoblastic leukemia: from genome to patient
doc. MUDr. Alexandra Kolenová, PhD.
(1/2016, Main topic ) - Case report of a patient with acute myeloid leukemia on maintenance therapy with gilteritinib after allogeneic transplantation
MUDr. Renáta Pizurová, MUDr. Kristína Mária Beláková, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ladislav Sopko, PhD.
(5/2025, Case reports ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - Current treatment approaches for acute myeloid leukemia in Slovakia
MUDr. Ladislav Sopko, PhD., MPH, MUDr. Barbora Žiaková, MUDr. Balázs Gálffy, PhD., MUDr. Jozef Lukáš, PhD.
(6/2025, Main topic ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Treatment of patients with FLT3 positive acute myeloblastic leukemia
MUDr. Firas Farkaš, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2019, Review articles ) - Decision making about the treatment of older patients with acute myeloblastic leukemia – case reports
MUDr. Iveta Oravcová, PhD., MUDr. Eva Mikušková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Vanda Mikudová, MUDr. Silvia Cingelová, PhD., doc. MUDr. Ľuboš Drgoňa, CSc.
(1/2018, Original articles & case reports ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes )
- Nové liečivá v EÚ registrované v roku 2014 (II.)
Mgr. Zuzana Šestáková, PharrmDr. Peter Stanko
(2/2015, New drugs )












